Furthermore, when the target was limited to grade II glioma, post-surgically untreated grade II gliomas showed that moderate-to-high expression of the NDRG1 protein was correlated with growth delay and improved progression-free survival, but not OS [34]. This evidence concerns the gene NDRG1 and central nervous system cancer.